This study analyses whether the inability of p53 to induce G 1 arrest after the restriction point relates to an inability to modulate pRb phosphorylation. Transient p53 overexpression in normal human diploid ®broblasts and p53-de®cient cancer cells led to increased levels of the cyclin-dependent kinase inhibitor p21
Introduction
Retinoblastoma (RB) and p53 gene de®ciencies occur in diverse human neoplasms. p53 alterations have been reported in approximately half of human malignancies encompassing a wide spectrum of tissues (Greenblatt et al., 1994) and although RB alterations are more tissuespeci®c (Horowitz et al., 1990) , some member of the pRb pathway (e.g., p16
INK4a , cyclin D1, or pRb) is frequently disrupted in many tumors (Sherr, 1996) . p53 was initially discovered as a cellular protein bound by SV40 T-antigen, and it was subsequently found that pRb is also inactivated by this viral oncoprotein (DeCaprio et al., 1988; Lane and Crawford, 1979; Linzer and Levine, 1979) . Replication of many DNA viruses requires inactivation of both p53 and pRb, which is typically achieved by expression of one or more such oncoproteins (Levine et al., 1991) . In addition, regulation of the activity of p53 and pRb is mediated by endogenous binding proteins. For example, the Mdm2 protein was ®rst reported to bind and inactivate p53 (Momand et al., 1992) . Mdm2 was later shown to interact with pRb and pRb-regulated E2F complexes as well (Martin et al., 1995; Xiao et al., 1995) , although recent studies suggest that deletion of Mdm2 has no additional eect on cell proliferation, cell cycle control or tumorigenesis when p53 is absent (Jones et al., 1996; McMasters et al., 1996) . p53 and pRb participate in several cell cycle checkpoint responses that contribute to maintaining genetic stability. DNA damage activates p53 (Kastan et al., 1991) , inducing a prolonged G 0 /G 1 cell cycle arrest resembling senescence in human ®broblasts (Di Leonardo et al., 1994; Linke et al., 1997) . Ribonucleotide depletion activates a reversible p53-dependent arrest in G 0 or early G 1 , resembling quiescence . p53 has also recently been implicated in regulating centrosome replication (Fukasawa et al., 1996) and in preventing DNA rereplication when spindle assembly is blocked (Cross et al., 1995; Di Leonardo et al., 1997) . Inactivation of p53 allows for the emergence of aneuploid cells and mutants with structural chromosome changes such as gene amplification (Livingstone et al., 1992; Yin et al., 1992) . Similarly, inactivation of pRb compromises the DNA damage-dependent arrest response (Almasan et al., 1995; Demers et al., 1994; Slebos et al., 1994) and the checkpoint activated by spindle inhibitors (Di Leonardo et al., 1997) and enables cells to enter the cycle when certain deoxyribonucleotides become limiting after treatment with antimetabolites such as methotrexate (Almasan et al., 1995) . However, inactivation of pRb in cells expressing wild-type p53 can lead to p53-dependent apoptosis in vitro (Almasan et al., 1995) and in vivo (Howes et al., 1994; Morgenbesser et al., 1994; Pan and Griep, 1994) . Thus, a collateral de®ciency in pRb and p53 allows cells to enter S phase under suboptimal conditions that contribute to genetic instability and accelerate tumorigenesis (Di Leonardo et al., 1993; Hartwell, 1992; Hartwell and Kastan, 1994) .
pRb modulation of G 1 -S phase progression is regulated, at least in part, by cell cycle-dependent phosphorylation (Buchkovich et al., 1989; Chen et al., 1989; DeCaprio et al., 1989) . pRb which is found predominantly in a hypophosphorylated form in early G 1 phase, binds to a subset of E2F complexes, thereby inhibiting their transcriptional activation potential (Hiebert et al., 1992) . As cells reach the restriction point in mid to late G 1 , pRb is phosphorylated by cyclin/cyclin-dependent kinase (Cdk) complexes, most notably cyclin D/Cdk4 and cyclin D/Cdk6. In addition, it is further phosphorylated near the G 1 -S transition by cyclin A/Cdk2 and, perhaps, by cyclin E/Cdk2 (reviewed by Bartek et al., 1996) . Phosphorylation of pRb prevents its inhibitory association with E2F complexes, allowing transcriptional activation of gene products required for S phase entry and DNA replication (DeGregori et al., 1995; Farnham et al., 1993; Slansky et al., 1993) . pRb then remains hyperphosphorylated under normal conditions until the transition from metaphase to anaphase (Durfee et al., 1993; Ludlow et al., 1993) .
The activity of the Cdks that phosphorylate pRb can be modi®ed by Cdk inhibitors, such as p21
Cip1/Waf1/Sdi1 (p21), members of the INK family (reviewed by Hunter and Pines, 1994) , and other kinases (reviewed by Morgan, 1995; Sherr, 1994) . Since p21 is induced by p53 (el-Deiry et al., 1993; Harper et al., 1995) , pRb phosphorylation can be aected by the diversity of stresses that activate p53 in G 1 , including DNA damage and ribonucleotide depletion (Demers et al., 1994; Di Leonardo et al., 1994; Dulic et al., 1994; Linke et al., 1996; Slebos et al., 1994) . Thus the net result of p53 activation in G 1 is to maintain pRb in its hypophosphorylated form, preventing activation of E2F-responsive gene products required for S phase progression (DeGregori et al., 1995; Slansky et al., 1993) .
Normal human diploid ®broblasts (NDF) that are girradiated in early to mid G 1 undergo a dose-dependent permanent G 0 /G 1 arrest (Di Leonardo et al., 1994) . In contrast, NDF irradiated in late G 1 fail to arrest. This suggests that a fundamental change occurs in the transduction of DNA damage signals at this juncture. The mechanism by which the damage response pathway becomes desensitized in late G 1 has not been elucidated. This study looks at the eects of p53 activation on pRb phosphorylation and cell cycle progression in late G 1 and S phase to determine if the inability of p53 to mediate cell cycle arrest beyond this point relates to dierences in its ability to modulate pRb phosphorylation. We show that p53 can be activated after the restriction point, leading to an accumulation of hypophosphorylated pRb. Although these late-G 1 cells contained predominantly hypophosphorylated pRb, they progressed into S phase. The data imply that the barrier to arrest in late G 1 is not due to an inability of p53 to receive damage signals or to mediate the accumulation of hypophosphorylated pRb. Rather, cells in late G 1 appear to have activated an irreversible program to enter S phase that is refractory to the functions of both p53 and pRb.
Results
Overexpression of p53 in asynchronous cells causes cell cycle arrest, induction of p21 and accumulation of hypophosphorylated pRb
We previously showed that transient overexpression of p53 by adenoviral transduction in p53-de®cient cell lines resulted in a dramatic decrease in S phase progression as measured by [ 3 H]thymidine uptake (Harris et al., 1996) . The use of adenovirus for p53 gene transfer provides an attractive tool to assess the eects of p53 expression on cell cycle regulation, as high gene transfer eciencies are obtained in many cell lines, and the episomal nature of the vector obviates the need for selection procedures. The H358 tumor cell line was chosen for initial studies because it lacks p53 protein and contains apparently normal pRb (Otterson et al., 1994; Takahashi et al., 1989) . NDF strain MRC-9 was studied in parallel to address the function of overexpressed p53 in normal human cells. and 1610 7 infectious units/ml for H358 and MRC-9, respectively. After 24 h samples were pulse-labeled with BrdU for 1 h and harvested for cell cycle or Western blot analysis. Cells harvested for cell cycle analysis were stained with propidium iodide and antiBrdU-FITC and analysed by bivariate¯ow cytometry (a and c). Numbers represent the percentage of cells in each cell cycle phase. The lower-left region represents G 0 and G 1 phase cells, the upper region represents S phase cells, and the lower-right region represents G 2 and M phase cells. b and d are the corresponding Western blots probed for pRb, p53 and p21. PAb1801 was used to detect p53 levels after V53 treatment due to its lower sensitivity (it does not detect p53 in wild-type ®broblasts) p53 modulation of pRb phosphorylation state SP Linke et al Asynchronous H358 or MRC-9 were infected with either a recombinant adenovirus containing a wild-type p53 gene (V53) or a control vector containing an empty expression cassette (V). Both constructs contain the cytomegalovirus immediate early promoter. The eects of p53 overexpression on cell cycle distribution were measured by¯ow cytometry 24 h after infection, and changes in p53, p21 and pRb were analysed by Western blot (Figure 1 ). pRb undergoes a mobility shift in SDS ± PAGE gels such that the hypophosphorylated form migrates faster than phosphorylated forms (Buchkovich et al., 1989) .
The number of cells in S phase in V53-infected cultures was substantially reduced compared to cultures infected with the vector control or uninfected cultures. V53-treated H358 cells accumulated in G 2 /M, whereas MRC-9 cells appeared to arrest in the subsequent G 1 (Figure 1a ,c). H358 cells underwent apoptosis at later time points (data not shown). These eects on cell cycle occurred concomitantly with increases in p53 and p21 and an accumulation of hypophosphorylated pRb (Figure 1b, d) . A doseresponse analysis showed that induction of p21 and accumulation of hypophosphorylated pRb correlated with the amount of p53 transgene expressed in both cell types (data not shown). Vector treatment alone had no eect in H358 and produced only slight decreases in the percentage of S phase cells and subtle elevations in p21 and hypophosphorylated pRb in MRC-9. Since cells with an intact p53 pathway arrest when even small numbers of DNA breaks are present (Di Leonardo et al., 1994; Huang et al., 1996) , it is possible that the slight changes observed in MRC-9 resulted from activation of the endogenous p53 pathway by a small fraction of linear adenovirus DNAs with unprotected ends.
Overexpression of p53 in cells synchronized in late G 1 or M leads to induction of p21 and an accumulation of hypophosphorylated pRb p53 loses its ability to mediate G 1 arrest in cells that have progressed into late G 1 , coinciding with the G 1 restriction point (Di Leonardo et al., 1994) . Two likely explanations are that p53 cannot receive DNA damage signals, or that it cannot induce downstream gene expression once cells traverse the restriction point. Several strategies were employed to investigate these possibilities.
We ®rst determined whether hypophosphorylated pRb accumulated when p53 was overexpressed in late G 1 phase or M phase. Asynchronous H358 or MRC-9 cells were synchronized in late G 1 with the plant amino acid analog mimosine (Lalande, 1990) . Cultures synchronized for 24 h were subsequently infected with V53 for an additional 24 h in the presence of mimosine. Samples were pulsed with bromodeoxyuridine (BrdU) for 30 min and analysed by¯ow cytometry to determine cell cycle distributions. H358 and MRC-9 cells treated with 200 mM mimosine displayed a signi®cant reduction in the percentage of S phase cells and an increase in G 0 /G 1 cells (Table 1) . Mimosine treatment of asynchronous cultures resulted in small populations of cells that did not incorporate BrdU (BrdU 7 ) yet had DNA contents between G 0 /G 1 and G 2 /M (i.e., they were presumably in S phase). It has been reported that mimosine can arrest cells that have entered S phase, likely due to inhibition of replication initiation (Mosca et al., 1992) . This subpopulation of BrdU 7 S phase cells is apparently incapable of engaging in DNA replication even after mimosine removal. H358 cultures contained about 20% of these BrdU 7 S phase cells, while MRC-9 cultures contained less than 5% after mimosine treatment of asynchronous cultures.
Mimosine-treated cells arrested with a G 0 /G 1 DNA content (Table 1) , and about half of the pRb was hyperphosphorylated (Figure 2a ). This is consistent with the arrest occurring in late G 1 , beyond the restriction point. The low levels of hyperphosphorylated pRb and increased levels of p21 in the asynchronous controls in MRC-9 in Figure 2a probably resulted from contact inhibition of a fraction of the cells, since they grow to a higher density than the drug or virus treated samples. Overexpression of 
Figure 2 p53 overexpression in late-G 1 or M-phase synchronized cells leads to p21 induction and accumulation of hypophosphorylated pRb. Asynchronous H358 or MRC-9 cells were left untreated (UN), or they were treated with 200 mM mimosine (Mimo) for 24 h to synchronize them in late G 1 . 100 mM colcemid (Colc) was used to synchronize H358 in mitosis. Cells were then infected with V53 or vector control (V) and harvested 24 h later (MRC-9, 1610 7 infectious units/ml; H358, 6610 6 infectious units/ml). Western blots were probed for pRb, p53, and p21. PAb1801 was used to detect p53 levels after V53 treatment. H358 cultures were next treated with the mitotic spindle inhibitor colcemid (100 mM), which arrests cells in prometaphase (Rieder and Palazzo, 1992) prior to when pRb becomes dephosphorylated at the transition from metaphase to anaphase (Ludlow et al., 1993) . The colcemid-treated cultures contained approximately 90% 4N (G 2 /M) phase cells within 48 h. Infection with V53 caused a slight increase in the G 2 /M fraction (Table 1) . A signi®cant fraction of the pRb in colcemid-arrested cells was hyperphosphorylated, as in the mimosine-arrested cells. Overexpression of p53 led to an induction of p21 and an accumulation of hypophosphorylated pRb in H358 cells, as observed in asynchronous and mimosine-arrested cells (Figure 2b ). Similar data were obtained in nocodazole-treated MRC-9 cells after p53 overexpression (data not shown). These data show that p53 overexpression can modulate p21 levels and pRb phosphorylation beyond the G 1 restriction point.
g-irradiation of asynchronous NDF results in accumulation of hypophosphorylated pRb and cell cycle arrest
Since the level of p53 was supraphysiological after adenovirus infection, g radiation was used to provide a more physiologically relevant condition to determine whether p53 could be activated to modulate pRb phosphorylation beyond the restriction point. A baseline was obtained for these analyses by determining the eect of 4 Gy g radiation on the cell cycle distribution and expression of p53, p21 and pRb in asynchronous MRC-9 cells. The fraction of cells in S phase was reduced and the fractions in G 0 /G 1 and G 2 / M were increased within 24 h of irradiation (Figure 3) , as observed in other NDF strains (Di Leonardo et al., 1994; Dulic et al., 1994) . This correlated with increases in the levels of p53 and p21 and an accumulation of hypophosphorylated pRb (Figure 3) . The increase in G 2 /M phase cells is consistent with the presence of a p53-independent G 2 DNA damage checkpoint delay, which may lead to p53-dependent arrest in the subsequent G 0 /G 1 if unrepaired damage is present .
g-irradiation of NDF in late-G 1 or early-S results in accumulation of hypophosphorylated pRb but does not inhibit cell cycle progression
We next determined whether g-irradiation in late G 1 would result in p53 and p21 induction and an accumulation of hypophosphorylated pRb. MRC-9 cells were synchronized in G 0 by contact inhibition, then released into 200 mM mimosine for 36 h to synchronize them in late G 1 . The synchronized population consisted of 89% cells with a G 0 /G 1 DNA content and 11% with a G 2 /M DNA content. Two samples were maintained in mimosine, one of which was treated with 4 Gy g radiation. Hyperphosphorylated pRb was predominant in the untreated sample, but pRb was completely hypophosphorylated 24 h after treatment with g radiation (Figure 4 ). The accumulation of hypophosphorylated pRb in irradiated cells took at least 4 h to occur (data not shown), and the level of detectable pRb decreased reproducibly by 24 h after irradiation.
We then analysed the consequences of g-irradiation on S phase cultures. Mimosine-arrested MRC-9 cells were released for 4 h, treated with 4 Gy g radiation or left untreated, and then harvested 24 h later (total of 28 h after release). At the time of the treatment (4 h after release from mimosine), 36% of cells showed BrdU incorporation (Figure 4 ). BrdU (10 mM) and nocodazole (0.05 mg/ml) were added immediately after treatment to label all cells that progressed into S phase and to prevent them from dividing. Hypophosphorylated pRb accumulated in the irradiated cells but not the untreated cells (Figure 4) . These results do not relate to the nocodazole treatment, since cells irradiated 4 h after release from mimosine and allowed to progress in the absence of nocodazole also accumulated hypophosphorylated pRb (data not shown). Despite the presence of predominantly hypophosphorylated pRb in the irradiated cells, nearly as many progressed to the subsequent G 2 /M (17%) as in the unirradiated control (20%) (Figure 4) . The dierence observed probably derives from a fraction of the mimosine-synchronized population being arrested suciently early in G 1 to be subject to g radiationinduced G 1 arrest. This is consistent with the slight reduction in the overall percentage of BrdU + cells Western blot analysis of pRb, p53, and p21. DO-1 was used to detect endogenous levels of p53 in MRC-9 cells. DO-1 provides higher sensitivity to p53 than PAb1801, which was used in the overexpression studies. b-actin con®rmed equal loading (data not shown) p53 modulation of pRb phosphorylation state SP Linke et al observed after the total 28 h release in the irradiated sample (39%) as compared with the untreated sample (44%) (Figure 4) . Irradiation of cells released into early S after an aphidicolin arrest also exhibited accumulation of hypophosphorylated pRb, indicating that the observed eects are not due to the synchronizing agent (data not shown).
Modulation of pRb phosphorylation state after girradiation is abrogated by expression of the HPV16 E6 oncoprotein
Pools of MRC-9 cells stably expressing HPV16 E6 and a neomycin-resistance marker (MRC-9E6) and isogenic controls expressing the neo marker alone (MRC-9neo) were next studied to determine whether p53 function was required for modulation of pRb phosphorylation state in response to g-irradiation after the restriction point. Cells expressing E6 have a non-functional p53 arrest pathway, as E6 hastens the degradation of p53 by ubiquitination (Werness et al., 1990) . Although additional functions have been proposed for E6, inactivation of p53 is sucient to abrogate g radiation-induced arrest, and none of the other putative E6 functions have been reported to aect the radiation response or pRb phosphorylation (e.g., Etscheid et al., 1994; Klingelhutz et al., 1996; Lechner and Laimins, 1994). Asynchronous MRC-9E6 cells contained nearly undetectable levels of p53 and lacked a g radiation-induced G 0 /G 1 arrest, whereas MRC-9neo cells contained detectable p53 and underwent a G 0 /G 1 arrest after irradiation ( Figure 5 and data not shown). Treatment of asynchronous, late-G 1 , or early S-phase MRC-9neo cells with 4 Gy g radiation resulted in an accumulation of hypophosphorylated pRb within 24 h, as observed in the parental MRC-9 cells (Figure 5a ). By comparison, pRb phosphorylation was not changed appreciably in irradiated MRC-9E6 cells (Figure 5b ). These data support the hypothesis that the accumulation of hypophosphorylated pRb after g-irridation requires functional p53.
NDF released from late G 1 with predominantly hypophosphorylated pRb progress through S phase Hyperphosphorylated pRb normally accumulates in late G 1 , enabling entry into and progression through S phase. Thus, treatments leading to accumulation of hypophosphorylated pRb, such as those described above, might be expected to alter progression into S phase. Since accumulation of hypophosphorylated pRb took more than 4 h to occur in MRC-9 cells after girradiation, it was possible that the progression seen in cells with predominantly hypophosphorylated pRb may have been due to its delayed accumulation. Therefore, mimosine-arrested MRC-9 cells were irradiated and then held in mimosine for an additional 24 h to allow for the majority of pRb to become hypophosphorylated. Cells were then released and allowed to progress for 4 h in the presence of BrdU to monitor their ability to enter S phase in the presence of predominantly hypophosphorylated pRb. Although irradiated cells contained predominantly hypophosphorylated pRb (Figure 6a ), their ability to enter S phase was comparable to that of the untreated control (Figure 6b) . Therefore, the presence of hypophosphorylated pRb after the G 1 restriction point has little (7) and the other treated with 4 Gy g radiation (+); both were harvested 24 h after the irradiation. Six other samples were synchronized in early S phase by releasing them from mimosine for 4 h. The samples were then treated, and nocodazole and BrdU were added (Mimo-4Noc+BrdU). Untreated (7) 
Discussion
The results presented here show that the failure of p53 to prevent cell cycle entry after the restriction point does not derive from an inability to modulate pRb phosphorylation state. When p53 was transiently overexpressed or induced by treatment with g radiation, hypophosphorylated pRb was observed not only in asynchronous NDF but also in cell populations arrested in late G 1 or M phase. This indicates that the damage signal received by p53 can cause accumulation of hypophosphorylated pRb at various phases of the cell cycle. The data also reveal that cells can proceed into S with hypophosphorylated pRb, as long as it is generated in late G 1 (after the restriction point). These data raise questions about the consequences of pRb hypophosphorylation after the G 1 restriction point and why cells become refractory to the eects of hypophosphorylated pRb after this critical decision point in the cell cycle (Pardee, 1989) .
The mechanism by which p53 modulates pRb phosphorylation state after cells commit to S phase is unknown. pRb has a half-life of 4 to 6 h (Chen et al., 1989) , and de novo synthesis of pRb in S, G 2 , and M presumably requires phosphorylation to generate and maintain the hyperphosphorylated species in these phases. We observed that 4 to 24 h was required for the accumulation of hypophosphorylated pRb subsequent to p53 overexpression or irradiation. Thus, it is reasonable to postulate that the accumulation of hypophosphorylated pRb we observed after irradiation may re¯ect both pRb protein turnover and concomitant inhibition of pRb phosphorylation. We do not favor a model involving synthesis of hypophosphorylated pRb in the absence of inhibition of phosphorylation, since cells in late G 1 or M treated only with synchronizing agents for 48 h maintained hyperphosphorylated pRb at similar levels as asynchronous controls.
Despite the accumulation of hypophosphorylated pRb following g-irradiation of late G 1 or S phase cells, p53 levels did not increase to the same extent as in irradiated asynchronous cells and p21 increases over the untreated controls were not evident. A trivial explanation for this phenomenon is that the eect of mimosine on p53 levels could have obscured the response (Khanna and Lavin, 1993). Alternatively, it is possible that p53 may be activated after the restriction point by a mechanism that does not require a signi®cant increase at the protein level. For example, phosphorylation of the p53 C-terminus enhances its sequence-speci®c DNA binding without an increase in level (Hupp et al., 1992) . In addition, p53 may have important targets other than p21 in late-G 1 and/or S phase, such as other Cdk inhibitors or phosphatase activators, that prevent accumulation of hyperphosphorylated pRb. Consistent with this, MEFs de®cient in p21 exhibit only a partial loss of p53-dependent G 0 / G 1 arrest when irradiated in early G 1 (Deng et al., 1995) . Also, In vitro phosphorylation of p53 by kinases prevalent in S phase and M phase results in dierential target gene activation created by preferential binding to certain promoters (Hecker et al., 1996; Wang and Prives, 1995) . These data suggest that speci®c molecular modi®cations to p53, mediated by kinases present at the G 1 -S transition, could elicit molecular consequences that are distinctly dierent from those produced by modi®cations that aect p53 function in G 0 or early G 1 cells. Although cyclin D and cyclin E levels were not signi®cantly altered after g-irradiation (data not shown), the net eect of the p53-dependent inhibition of their associated kinase activities was to prevent the accumulation of hyperphosphorylated pRb.
The ability of a physiological event such as DNA damage to produce a p53-dependent change in pRb phosphorylation in all cell cycle phases analysed suggests that such alterations would have consequences on cell cycle progression. However, we found that hypophosphorylated pRb present in late-G 1 did not signi®cantly aect progression into S phase. This is in agreement with studies showing that pRb, p16, antibodies to cyclin D1, or pRb phosphatases can arrest cells when microinjected in early to mid G 1 , but not in late G 1 or S (Alberts et al., 1993; Goodrich et al., 1991; Lukas et al., 1995) . Our study extends these ®ndings by providing evidence that pRb can be modi®ed to exist in a hypophosphorylated state by a response to DNA damage signal transduction path- showing that DNA rereplication occurs in the presence of spindle inhibitors in cells with non-functional p53, but not in cells with functional p53, raises the intriguing possibility that pRb might also participate in this`spindle checkpoint' (Cross et al., 1995; Di Leonardo et al., 1997) . Consistent with this possibility, we recently found that pRb-de®cient mouse embryo ®broblasts and HPV16 E7-expressing NDF rereplicate when challenged with mitotic spindle inhibitors (Di Leonardo et al., 1997) . The inability of hypophosphorylated pRb to attenuate cell cycle progression in late G 1 or S may be explained in several ways. For example, the hypophosphorylated pRb produced in early G 1 may not be identical to that generated later in the cycle with regard to its phosphorylation, which may not be revealed by SDS ± PAGE. It is also possible that the high stability of the E2F-regulated biosynthetic enzymes required for S phase progression, such as DHFR and TS, makes the re-establishment of inhibition at the level of transcription insucient to turn them o after they are produced in late G 1 . This is supported by the observation that phosphorylation of E2F-1 by cyclin A/Cdk2 in S phase inhibits its ability to bind DNA, shutting o transcription of E2F-regulated genes well before the end of S phase (Dynlacht et al., 1994; Krek et al., 1994) . This process may be necessary to allow replication to occur through these genes (Krek et al., 1995) . Phosphorylation of E2F complexes by cyclin A/CDk2 may also prevent reassociation with pRb, regardless of its phosphorylation state (Fagan et al., 1994; Xu et al., 1994) .
Alternatively, it is possible that events important for initiation at DNA replication origins may occur prior to the mimosine block. This is supported by recent evidence that E2F may directly regulate transcription of the newly-identi®ed human origin recognition complex gene HsOrc1 (Ohtani et al., 1996) . In addition, Mdm2 can bind to pRb (inhibiting its growth regulatory function) and to E2F (augmenting its transactivation potential), so induction of Mdm2 in late G 1 could also prevent hypophosphorylated pRb from inhibiting E2F (Martin et al., 1995; Xiao et al., 1995) . In any event, cells arrested in late G 1 maintain the ability to initiate DNA replication and complete S phase, despite the presence of predominantly hypophosphorylated pRb. The inability of hypophosphorylated pRb to induce arrest after cells have passed the G 1 restriction point emphasizes that traversing this checkpoint creates an irrevocable license to enter into and proceed through S phase, even under conditions that can lead to genetic damage.
Materials and methods

Cell culture and treatments
NCI-H358 (non-small cell lung carcinoma) and MRC-9 (human diploid embryonic lung ®broblast) cells were obtained from the ATCC and maintained in DMEM supplemented with 10% fetal bovine serum and 1% sodium pyruvate at 378C and 7% CO 2 . MRC-9 cells were used up to 25 ± 30 population doublings. g-irradiation was performed at room temperature using a 60 Co g-irradiator (Gammabeam 150-C) at a distance of 40 cm and a rate of approximately 3.0 Gy/min (1 Gy=100 rads).
A replication-de®cient recombinant human adenovirus encoding wild-type p53 under the control of the human cytomegalovirus immediate early promoter (V53) was used to exogenously express p53. An adenovirus consisting of the human cytomegalovirus promoter with an empty expression cassette (V) was used as a control. Virus was produced and titered using an infectious assay in 293 embryonic kidney cells, which provide E1 function in trans (Wills et al., 1994 (Wills et al., , 1995 .
Previous studies have shown dierential transduction eciencies between H358 and MRC-9 cells using a recombinant adenovirus encoding b-galactosidase (Harris et al., 1996) . Therefore, the adenovirus concentrations used in infections were slightly higher for MRC-9 cells (1610 7 infectious units/ml) than for H358 cells (3 ± 8610 6 infectious units/ml). b-galactosidase expression studies at these concentrations resulted in comparable percentages of cells expressing the transgene. Dose response experiments covered a concentration range between 3610 5 and 1610 7 infectious units/ml.
Generation of E6-expressing MRC-9
Pools of MRC-9 expressing a neomycin resistance gene (MRC-9neo) or expressing neomycin resistance and the oncogenic HPV16 E6 protein (MRC-9E6) were prepared by retroviral gene transduction as described by Halbert et al. (1992) using murine PA317 producer lines (provided by Dr D Galloway, Fred Hutchinson Cancer Research Center, Seattle, WA). These MRC-9 pools were maintained as described above with the addition of 200 mg/ml G-418 sulfate.
Flow cytometric cell cycle analysis
Cells were incubated in 10 mM BrdU to label S phase cells. After harvest by trypsinization, cells were ®xed in 70% ethanol until the day of analysis. Cells were treated with 0.1 M HCl containing 0.5% Triton X-100 to extract histones, followed by boiling and rapid cooling to denature the DNA. Cells were then incubated with antiBrdU-FITC (PharMingen, San Diego, CA) and counterstained with propidium iodide containing RNase. Samples were run on a Becton-Dickinson FACScan using color compensation when appropriate. Data analysis was done using SunDisplay3 (J Trotter, Salk Institute Flow Cytometry Lab, La Jolla, CA). Cellular debris and ®xation artifacts were gated out. Events with a 2n DNA content were gated as %G 0 /G 1 , events with a 4n DNA content were gated as %G 2 /M, and BrdU + events with intermediate DNA content were gated as %S in pulselabeling experiments. In continuous-labeling experiments, BrdU + G 2 /M events were also scored.
Western blotting
Cell lysates were prepared using lysis buer (50 mM TrisHCl pH 7.5, 250 mM NaCl, 0.1% NP-40, 50 mM NaF, 5 mM EDTA, 10 mg/ml aprotinin, 10 mg/ml leupeptin and 1 mM PMSF), and supernatants were collected after one freeze-thaw cycle. Samples were normalized for total protein content by a Bradford assay (Bio-Rad), loaded onto pre-cast Tris-glycine gels (Novex), and separated by SDS ± PAGE. Typically, 5 to 10 mg of total protein was loaded per lane. After transfer onto 0.2 mm nitrocellulose membranes, proteins were detected using the following antibodies: p53, PAb1801 (Novacastra) or DO-1 (Oncogene Science); pRb, mAb 3C8 ; p21, Ab-1 (Oncogene-Science); and b-actin, AC-15 (Sigma). Enhanced chemiluminescence (Amersham) was used as a detection system.
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